FABP4 and metabolic syndrome: Furthermore, clinical research also suggested that FABP4 played critical roles in macrophage cholesterol trafficking and inflammation, and may promote the obesity development [9], insulin resistance [10], metabolic syndrome [11], diabetes [12], gestational diabetes mellitus [13], hypertension [14] and atherosclerosis [5,15–17].